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Background: Meningeal carcinomatosis and hypercoagulability associated with malignancy are typical late stage
complications in cancer patients. The co-occurrence of meningeal carcinomatosis and cerebral infarction related to
hypercoagulability associated with malignancy in an individual as the initial manifestation of malignancy has not
been previously reported.
Case presentation: Herein, we report the case of an 80-year-old patient who presented with meningeal
carcinomatosis and hypercoagulability related to malignancy as the initial manifestation of occult gastric cancer.
The patient displayed consciousness disturbance, mild left facial paralysis, and bilateral positive Babinski’s sign.
Using brain magnetic resonance imaging, the patient was diagnosed as having acute multiple cerebral infarctions.
Cerebrospinal fluid (CSF) cytology showed adenocarcinoma and upper gastrointestinal endoscopy disclosed
scirrhous gastric cancer. The patient presented with headache, fever, and meningeal irritation with a subacute
course. Tuberculous or fungal meningitis was initially suspected; however, cytological evidence of adenocarcinoma
in the CSF led to the diagnosis of meningeal carcinomatosis.
Conclusion: The comorbidity of hypercoagulability associated with malignancy and meningeal carcinomatosis
should be considered in a patient presenting with multiple cerebral infarctions, progressive disturbance of
consciousness, fever, and meningeal irritation.
Keywords: Multiple cerebral infarctions, Disturbance of consciousness, Meningeal irritation, Trousseau’s syndrome,
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Meningeal carcinomatosis is characterized by diffuse
invasion of tumor cells in the leptomeninges and cerebro-
spinal fluid [1], which occurs in 3-8% of all cancer patients.
Among patients with any type of solid tumors, the highest
incidence of meningeal carcinomatosis has been reported
in patients with breast cancer (12-34%) and lung cancer
(10-26%) [2], while the occurrence of meningeal car-
cinomatosis is rare in patients with gastric cancer with a* Correspondence: keisuke@dokkyomed.ac.jp
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reproduction in any medium, provided the orreported incidence of 0.06-0.17% [3,4]. Nevertheless, in
autopsy studies, evidence of meningeal involvement was
found in approximately 20% of cancer patients with neuro-
logical signs and symptoms [1,5].
Malignant tumors, such as lung cancer, prostatic cancer,
brain tumors, gastrointestinal cancer, uterine cancer, and
ovarian cancer [6], are often associated with excessive
coagulation; arterial and venous thrombosis is also a
frequent complication [7]. Meningeal carcinomatosis
and hypercoagulability associated with malignancy are
treatment-resistant complications of malignancy. The
early detection of both conditions is clinically important.
However, the co-occurrence of meningeal carcinomatosisal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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ated with malignancy in the same individual, especially as
the early manifestation of malignancy, has not been previ-
ously reported. Herein, we report a patient who presented
with meningeal carcinomatosis and cerebral infarction
due to hypercoagulability related to malignancy, which
were the initial manifestations of occult gastric cancer.
Case presentation
An 80-year-old woman developed unsteadiness of gait
and required assistance to walk one week after she noted
lower back pain. One week later, the patient presented
with headache, nausea, and low-grade fever and was
admitted to a local hospital. Acute multiple cerebral
infarctions were diagnosed via brain magnetic resonance
imaging (MRI), and anti-coagulant therapy was initiated.
However, despite continuing medical treatment for 7 days,
consciousness disturbance developed and she was trans-
ferred to our hospital. At the time of admission, the
patient was 155 cm tall and weighed 61 kg. Her body
temperature was 37.4°C, her blood pressure was 145/
85 mmHg, and her pulse rate was 66/min. There was no
blood pressure differential between the right and left arms.
The physical examination, including palpations of the
lymph nodes, chest and abdomen, was unremarkable.
There was mild edema in the lower legs. Neurological
examination revealed mild consciousness disturbance with
a Glasgow Coma Scale (GCS) of 12 (E3V4M5), mild left
facial paralysis, and bilateral positive Babinski’s sign. The
patient displayed no motor weakness or sensory distur-
bances. Marked nuchal stiffness and a positive Kernig’s
sign were observed.
The patient’s laboratory data showed a white blood cell
count of 12,100/μL with 87.3% neutrophils, C-reactive
protein levels of 11.69 mg/dL, and D-dimer levels of
18.1 μg/mL. Cerebrospinal fluid (CSF) analysis disclosed
5 mononuclear cells/μL, a glucose level of 42 mg/dL
(CSF-blood glucose ratio: 0.35), and a protein value of
46 mg/dL (Table 1). An electroencephalogram revealed
frequent bilaterally asynchronous sharp wave activities.








Adenosine deaminase <2.0 U/L
CSF-blood glucose ratio 0.35intensities in the right cerebellar hemisphere, corona
radiata, caudate nucleus, and the left parietal lobe on
diffusion-weighted imaging (Figure 1A, B), with corre-
sponding reduced apparent diffusion coefficient maps.
No enhancement was observed in these lesions or the men-
inges on post-contrast T1-weighted images (Figure 1C, D).
MR angiography showed intracranial vessel irregularities
and stenoses of the right middle cerebral artery and verte-
bral artery. Electrocardiography displayed a sinus rhythm.
Neither a potential cardiac source of embolism nor a source
of the right-to-left shunt, including patent foramen ovale,
was demonstrated via transthoracic and transesophageal
echocardiography. A computed tomography scan of the
chest detected calcification of the aortic arch. The patient
was treated with intravenous heparin.
The subacute clinical course, marked nuchal stiffness,
and mild mononuclear pleocytosis with a decreased CSF-
blood glucose ratio (Table 1) led us to consider meningo-
encephalitis due to tuberculosis or fungi; subsequently,
antitubercular and antifungal drugs were administered.
However, the CSF exams resulted in a negative crypto-
coccus antigen test and a low adenosine deaminase level
(<2.0 IU/L). Additionally, CSF culture for bacteria, acid-
fast bacilli and fungi was negative. The CSF cytology on
admission revealed adenocarcinoma (Figure 2). Tumor
markers were within normal ranges. The chest, abdominal,
and pelvic computed tomography and gallium scintigraphy
findings showed no evidence of malignancy. However,
upper gastrointestinal endoscopy disclosed scirrhous
gastric cancer, which was pathologically diagnosed as
adenocarcinoma (signet-ring cell). The final diagnosis
was meningeal carcinomatosis and excessive coagula-
tion related to occult gastric cancer. Following discus-
sion with the patient’s family, and based on the patient’s
age, worsening consciousness levels (GCS of 6 on week 3),
and poor performance status, she was transferred to the
other hospital 22 days after admission, and supportive care
rather than active management was administered.
Discussion
In this report, we present the first case of the co-occur-
rence of cerebral infarction due to hypercoagulability asso-
ciated with malignancy and meningeal carcinomatosis as
the initial manifestation of occult gastric cancer. Our
patient displayed headache, fever, and meningeal irritation
with a subacute course. Although tuberculous or fungal
meningitis was initially suspected, cytological evidence of
adenocarcinoma in the CSF led to a diagnosis of menin-
geal carcinomatosis. Nonbacterial thrombotic endocarditis
(marantic endocarditis) and infective endocarditis [8] or
bacterial meningoencephalitis [9] can present with fever
and acute multiple cerebral infarctions. However, in the
patient reported here, no vegetation was detected via
transthoracic or transesophageal echocardiography, and
Figure 1 Brain magnetic resonance images. A, B; Diffusion-weighted images show high signal intensities in the right cerebellar hemisphere
and in the deep white matter adjacent to the bilateral lateral ventricles and subcortices (arrowheads). C, D; Post-contrast T1-weighted images
reveal no meningeal enhancement.
Kawasaki et al. BMC Neurology 2014, 14:160 Page 3 of 5
http://www.biomedcentral.com/1471-2377/14/160the CSF bacterial culture was negative. Hypercoagulability
was likely the cause of cerebral infarction in our patient.
Meningeal carcinomatosis usually occurs in a patient
who has a malignancy of known origin during the dis-
ease course and is typically a relatively late complication.
The diagnosis can be made on the basis of CSF cyto-
logical findings. The sensitivity of the diagnosis for men-
ingeal carcinomatosis increases as CSF cytology tests are
repeated and the results are confirmed. The prognosis of
untreated meningeal carcinomatosis is reported to be
poor, with a median survival of 4–6 weeks from diag-
nosis [1]. Additionally, the type of primary cancer is a
major prognostic factor. In a series of 90 patients with
meningeal carcinomatosis who received focal irradiation
and intraventricular methotrexate, 61% of the patients
with breast cancer showed neurological improvement
with a median survival of 7.2 months, while 39% of the
lung cancer patients showed neurological improvement
with a median survival of 3–4 months [10]. However,
although rare, meningeal carcinomatosis can be the initialand early manifestations of the malignancy (as was ob-
served in our patient) [3,11-18]. In these patients, the
diagnosis of meningeal carcinomatosis contributed to the
identification of the primary malignancy and the primary
tumors were found in the stomach [3,12], the lung [14,16],
the bronchus [15] and the colon [13]. Common neuro-
logical presentations are headache [3,11,15] and bilateral
deafness [12-14]. Radiation therapy and chemotherapy
including intrathecal methotrexate are used in patients
with meningeal carcinomatosis [3,11,12,15,16]. However,
the prognosis remains poor, with a survival of 0.4-12
months from diagnosis. Cerebral infarction, which was
likely due to tumor embolism and complicated with men-
ingeal carcinomatosis, has been reported [11]. In contrast,
our patient displayed cerebral infarction due to hyperco-
agulability associated with malignancy. High-grade fever
may be uncommon.
Our patient displayed multiple cerebral infarctions
caused by excessive blood coagulation, which was con-
firmed by elevated D-dimer levels and was related to the
Figure 2 The results of CSF cytology. The cytology obtained from the CSF reveals adenocarcinoma.
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syndrome associated with cancer or malignancy-related
thromboembolism is also known as Trousseau’s syn-
drome [19].
Regarding the mechanism of the hypercoagulability state
in cancer patients, tumor necrosis factor, interleukin-1
and interleukin-6, which are released by monocytes or
macrophages, lead to endothelial damage. Additionally,
interactions between tumor cells and macrophages ac-
tivate platelets, factor XII, and factor X, leading to the
generation of thrombin and thrombosis [7]. Based on the
imaging findings in our patient, we concluded that the
cerebral infarction was due to hypercoagulability and not
due to the meningeal invasion of malignant cells. There-
fore, meningeal carcinomatosis may have had a significant
impact on the clinical course of this patient; however the
role of meningeal carcinomatosis in the development
of cerebral infarction was unclear in our patient. These
co-occurrences may be coincidental.
Embolism is thought to be a common cause of stroke
in cancer patients. Cestari et al. reported that embolic
stroke is responsible for 54% of the strokes observed
in cancer patients, whereas atherosclerosis accounts
for 22% of these strokes [20]. Nonbacterial thrombotic
endocarditis is characterized by the deposition of thrombi
on previously undamaged heart valves in the absence
of a bloodstream bacterial infection, which likely results
from the hypercoagulable state and increased levels of
cytokines associated with cancer [21]. In an autopsy study,nonbacterial thrombotic endocarditis (18.5%) and intravas-
cular coagulation (9.6%) were the most common etiologies
for cerebrovascular disease in cancer patients [22].
The incidence of stroke in patients with cancer is
reported to be 0.12% with lung cancer as the most
common primary lesion, followed by brain tumor and
prostatic cancer. Metastasis to the brain or meninges
was found in 6% of the cancer patients who developed
stroke; among these patients, 2% had metastases to the
central nervous system, as detected following the stroke
onset. In a hypercoagulability state related to malignancy,
removal of the causative tumor is the primary approach;
however, this is difficult in many patients, including our
patient, particularly during late-stage malignancy. A hy-
percoagulability state involves multiple mechanisms, and
heparin use is recommended because it has the ability
to irreversibly inactivate both activated factor Xa and
thrombin, interrupt fluid-phase thrombosis and sup-
press secondary platelet activation [19]. Therefore, we
administered heparin to our patient; however, the recur-
rence of cerebral infarction could not be prevented. The
prognosis of a hypercoagulability state related to malig-
nancy is poor. A 1-year survival rate of 12% was observed
in patients who received a diagnosis of cancer simultan-
eously with or following an episode of venous throm-
boembolism [23]. A large study including 1,874 cancer
patients found that the median survival following venous
thrombosis and arterial thrombosis was 16.7 months
and 7.7 months, respectively [24]. Additionally, in a
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stroke, the rates of recurrent thromboembolism were 21%,
31%, and 37% at 1, 3, and 6 months, respectively; adeno-
carcinoma histology was independently associated with
recurrent thromboembolism [25].
Conclusion
We present the first case report of the co-occurrence of
hypercoagulability related to malignancy and meningeal
carcinomatosis as the initial manifestation of occult gastric
cancer. Although rare, the comorbidity of hypercoagula-
bility related to malignancy and meningeal carcinomatosis
should be considered in a patient showing multiple cere-
bral infarctions, progressive disturbance of consciousness,
fever, and meningeal irritation.
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